(19)
(11) EP 1 385 873 A2

(12)

(88) Date of publication A3:
20.06.2002

(43) Date of publication:
04.02.2004 Bulletin 2004/06

(21) Application number: 01934229.4

(22) Date of filing: 07.05.2001
(51) International Patent Classification (IPC)7C07K 7/08, A61K 47/48, C12N 15/11
(86) International application number:
PCT/IB2001/000926
(87) International publication number:
WO 2001/090139 (29.11.2001 Gazette 2001/48)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(71) Applicant: SUPRATEK PHARMA, INC.
Dorval,Quebec H9S T58 (CA)

(72) Inventors:
  • TCHISTIAKOVA, Lioudmila
    Laval, Quebec H7V 1J8 (CA)
  • LI, Shengmin
    St-Laurent, Quebec H4N 2H4 (CA)
  • PIETRZYNSKI, Grzegorz
    Montreal, Quebec H4P 1C7 (CA)
  • ALAKHOV, Valery
    Baie D'Urfe, Quebec H9X 3V4 (CA)

(74) Representative: Arends, William Gerrit et al
Lloyd WiseCommonwealth House1-19 New Oxford Street
London WC1A 1LW
London WC1A 1LW (GB)

   


(54) A LIGAND FOR ENHANCING ORAL AND CNS DELIVERY OF BIOLOGICAL AGENTS